IQVIA Holdings Inc. (IQV) Financial Statements
Historical financial data — 42 statements covering FY2016–FY2025
Iqvia is a global leader in clinical research and technology solutions for the life science industry. Formed in 2016 from the merger of Quintiles and IMS Health, it combined clinical trial services...
IQVIA Holdings Inc.'s revenue increased 5.9% year over year, from $15.40B to $16.31B.
Net income decreased 0.9% over the same period, from $1.37B to $1.36B.
Over the 9-year period from FY2016 to FY2025, revenue grew by 137% in total.
Total debt increased by 8.1% to $13.88B.
The debt-to-equity ratio stands at 2.14, indicating a high leverage profile.
Operating cash flow declined 2.3% to $2.65B.
IQVIA Holdings Inc. maintains a moderate net profit margin of 8.3%.
Recent Financial Statements
Quarterly figures are standalone quarters, de-cumulated from YTD filings (Q4 = FY − Q3 YTD when not reported).
| Period | Revenue | Net Income | EBIT | Op. Cash Flow | Total Assets | Total Debt | Equity |
|---|---|---|---|---|---|---|---|
| Q3 FY2024 | $3.90B+2.1% | $285.0M | $550.0M | $721.0M | $27.18B | $12.29B | $6.97B |
| Q4 FY2024 | $3.96B+1.6% | $437.0M | $626.0M | $885.0M | $26.90B | $12.84B | $6.07B |
| Q1 FY2025 | $3.83B-3.3% | $249.0M | $496.0M | $568.0M | $27.32B | $13.11B | $5.98B |
| Q2 FY2025 | $4.02B+4.9% | $266.0M | $506.0M | $443.0M | $28.63B | $14.18B | $5.78B |
| Q3 FY2025 | $4.10B+2.1% | $331.0M | $553.0M | $908.0M | $28.73B | $12.79B | $6.16B |
| Q4 FY2025 | $4.36B+6.4% | $514.0M | $627.0M | $735.0M | $29.94B | $13.88B | $6.50B |
| Q1 FY2026 | $4.15B-4.9% | $274.0M | $514.0M | $618.0M | N/A | N/A | N/A |
| Q2 FY2026 | $4.37B+5.2% | $256.0M | $506.0M | $558.0M | N/A | N/A | N/A |
Balance Sheet Summary (FY2025)
IQVIA Holdings Inc. (IQV) Financial Statements & Revenue History
IQVIA Holdings Inc. (IQV) is a US-listed stock operating in the Healthcare sector, specifically the Services-Commercial Physical & Biological Research industry trading at $266.90 with a market capitalization of $44. This page provides 42 historical financial statements for IQVIA Holdings Inc., including income statement, balance sheet, and cash flow data across multiple reporting periods. Most recently, IQVIA Holdings Inc. reported revenue of $16.3 billion, representing 5.9% year-over-year growth. The net profit margin of 8.3% indicates moderate profitability. The debt-to-equity ratio of 2.14 signals high leverage.
IQV Income Statement, Balance Sheet & Cash Flow
The financial statements table above shows IQVIA Holdings Inc.'s revenue, net income, gross profit, EBIT, operating cash flow, total assets, total debt, and shareholders' equity across the most recent reporting periods. Year-over-year growth rates help identify whether IQV is accelerating or decelerating in terms of top-line revenue and bottom-line profitability.
- Revenue trend: Track IQV's top-line growth across quarters and fiscal years to identify acceleration or deceleration in the business.
- Profitability: Net income and gross profit margins reveal how efficiently IQVIA Holdings Inc. converts revenue into earnings.
- Balance sheet health: Total assets, liabilities, debt, and equity provide a snapshot of IQV's financial position and leverage.
- Cash flow: Operating cash flow shows how much cash the business generates from its core operations, which is critical for funding dividends, buybacks, and growth.
How to Use IQV Financial Data
Investors use IQVIA Holdings Inc.'s financial statements to assess the company's financial health, growth trajectory, and valuation. Key metrics to focus on include:
- Revenue growth rate: Consistent double-digit revenue growth suggests a strong business; declining revenue may signal competitive pressure.
- Net profit margin: Higher margins indicate a more efficient business with pricing power. Compare IQV's margins to sector peers for context.
- Debt levels: High debt-to-equity ratios increase financial risk, especially in rising-rate environments. Low debt provides flexibility.
- Valuation multiples: See how IQV's P/E, P/S, and EV/EBITDA ratios compare to historical levels.
- Full analysis: View IQV's financial health score, earnings, and pre-market pricing.
Financial data is sourced from IQVIA Holdings Inc.'s SEC filings (10-K, 10-Q) via Polygon.io and Finnhub.IQV trades on NYSE/NASDAQ. This page is for informational purposes only and is not financial advice.